Fortrea
Runs clinical trials and development services for drug, biotech, and device sponsors.
$18.89
After-hours close+0.09 (+0.51%)
At close$18.80(−0.34%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.23 | — | — |
| Jul 2026 | $0.18 | $0.23 | +27.5% |
| May 2026 | $0.03 | $0.16 | +433.3% |
| Feb 2026 | $0.16 | $0.09 | −43.8% |
| Nov 2025 | $0.16 | $0.12 | −25.0% |
The latest year is open to everyone — the 14 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | $0.23 | — | — | $670.5M | — | — |
| Jul 29, 2026 | $0.18 | $0.23 | +27.5% | $647.6M | $678.2M | +4.7% |
| May 5, 2026 | $0.03 | $0.16 | +433.3% | $628.5M | $636.5M | +1.3% |
| Feb 26, 2026 | $0.16 | $0.09 | −43.8% | $665.2M | $660.5M | −0.7% |
| Nov 5, 2025 | $0.16 | $0.12 | −25.0% | $665.2M | $701.3M | +5.4% |
The latest year is open to everyone — the 14 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 3, 2025 | ||||||
| Nov 8, 2024 | ||||||
| Aug 12, 2024 | ||||||
| May 13, 2024 | ||||||
| Mar 11, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 14, 2023 | ||||||
| Mar 31, 2023 | ||||||
| Dec 31, 2022 | ||||||
| Sep 30, 2022 | ||||||
| Jun 29, 2022 | ||||||
| Mar 30, 2022 | ||||||